Walleye Trading’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.2K Buy
+394
New +$33.4K ﹤0.01% 3710
2026
Q1
Sell
-1,200
Closed -$146K 4719
2025
Q4
$146K Sell
1,200
-78
-6% -$9.79K ﹤0.01% 3545
2025
Q3
$143K Buy
+1,278
New +$150K ﹤0.01% 3544
2025
Q1
Sell
-1,283
Closed -$88.2K 4712
2024
Q4
$80K Buy
1,283
+1,236
+2,630% +$115K ﹤0.01% 3647
2024
Q3
$7.38K Sell
47
-1,179
-96% -$182K ﹤0.01% 3805
2024
Q2
$185K Buy
1,226
+74
+6% +$8.88K ﹤0.01% 3134
2024
Q1
$85.2K Buy
+1,152
New +$94.9K ﹤0.01% 3834
2023
Q4
Sell
-6,128
Closed -$336K 5498
2023
Q3
$336K Buy
6,128
+5,373
+712% +$387K ﹤0.01% 3277
2023
Q2
$63.4K Buy
755
+426
+129% +$32.6K ﹤0.01% 3892
2023
Q1
$24.9K Buy
329
+173
+111% +$12K ﹤0.01% 4215
2022
Q4
$9.63K Buy
+156
New +$8.29K ﹤0.01% 4482
2021
Q3
Sell
-6,439
Closed -$214K 5719
2021
Q2
$214K Buy
+6,439
New +$178K ﹤0.01% 3856

Other funds holding TMDX

Walleye Trading's TMDX Position: Q2 2026 in Review

Walleye Trading opened a new position in Transmedics (TMDX) in Q2 2026: 394 shares worth $26.2K. The stake represents ﹤0.01% of the portfolio and ranks #3710 among its holdings. This is a return to the name: Walleye Trading previously reported a position in TMDX as recently as Q4 2025.

Walleye Trading first reported a position in TMDX in Q2 2021 and has held it in 12 quarters since. The position peaked at $336K in Q3 2023. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Walleye Trading held 394 shares of Transmedics worth $26.2K as of Q2 2026.
  • Transmedics was a new Walleye Trading position in Q2 2026.
  • Transmedics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3710 holding.
  • Walleye Trading first reported a position in Transmedics in Q2 2021 and has held it in 12 quarters since.
  • Walleye Trading's Transmedics position peaked at $336K in Q3 2023.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.